Published in Biochemistry on August 30, 1983
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev (2008) 2.65
Biominerals--hierarchical nanocomposites: the example of bone. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.20
Primary structure and phosphorylation of dentin matrix protein 1 (DMP1) and dentin phosphophoryn (DPP) uniquely determine their role in biomineralization. Biomacromolecules (2011) 1.11
Molecular evolution of dentin phosphoprotein among toothed and toothless animals. BMC Evol Biol (2009) 0.98
Production and characterization of antibodies against murine dentine phosphoprotein. Biochem J (1985) 0.96
Dentin phosphoprotein (DPP) activates integrin-mediated anchorage-dependent signals in undifferentiated mesenchymal cells. J Biol Chem (2011) 0.93
Domain structure and sequence distribution in dentin phosphophoryn. Biochem J (1991) 0.86
DPP in the matrix mediates cell adhesion but is not restricted to stickiness: a tale of signaling. Cell Adh Migr (2012) 0.83
Post-translational processing of chicken bone phosphoproteins. Identification of the bone phosphoproteins of embryonic tibia. Biochem J (1990) 0.82
The role of acidic phosphoproteins in biomineralization. Connect Tissue Res (2014) 0.82
Acidic domain in dentin phosphophoryn facilitates cellular uptake: implications in targeted protein delivery. J Biol Chem (2013) 0.81
Effects on dentin treated with eluted multi-mineral varnish in vitro. Open Dent J (2012) 0.80
Synthesis of bone-like nanocomposites using multiphosphorylated peptides. Acta Biomater (2014) 0.77
Dentin phosphoprotein binds annexin 2 and is involved in calcium transport in rat kidney ureteric bud cells. J Biol Chem (2013) 0.77
Characteristics of phosphorylated and non-phosphorylated dentine phosphoprotein. Biochem J (1992) 0.75
Dentin phosphophoryn in the matrix activates AKT and mTOR signaling pathway to promote preodontoblast survival and differentiation. Front Physiol (2015) 0.75
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell (1991) 9.73
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell (1996) 6.52
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (1997) 4.83
Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res (1991) 3.47
Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem (1994) 3.37
Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol (1999) 2.91
Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem (1993) 2.63
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res (1990) 2.40
Molecular aspects of tumor cell invasion and metastasis. Cancer (1993) 2.24
Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A (1992) 2.18
Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol (1992) 2.17
Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst (1991) 2.15
Metalloproteinases and cancer invasion. Semin Cancer Biol (1990) 2.07
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol (1993) 2.01
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res (2001) 1.99
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest (1998) 1.95
Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol (1993) 1.88
Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol (1990) 1.82
Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem (1999) 1.78
Validation of a model of colon cancer progression. J Pathol (2000) 1.76
Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Miner (1990) 1.70
The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J (1994) 1.68
Peritubular dentin formation: crystal organization and the macromolecular constituents in human teeth. J Struct Biol (1999) 1.67
Microanalysis and characterization of acidic glycosaminoglycans in human tissues. Anal Biochem (1970) 1.66
Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol (1993) 1.65
Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol (2000) 1.64
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry (1994) 1.63
The phosphoprotein of the dentin matrix. Biochemistry (1967) 1.62
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer (1998) 1.58
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol (1997) 1.53
The carboxyl-terminal domain of phosphophoryn contains unique extended triplet amino acid repeat sequences forming ordered carboxyl-phosphate interaction ridges that may be essential in the biomineralization process. J Biol Chem (1996) 1.52
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res (1991) 1.52
Cloning and sequence determination of rat dentin sialoprotein, a novel dentin protein. J Biol Chem (1994) 1.48
The non-collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II (DGI-II). J Dent Res (2000) 1.47
Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem (1992) 1.46
Fourier transform IR spectroscopy of collagen and gelatin solutions: deconvolution of the amide I band for conformational studies. Biopolymers (1988) 1.42
Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy. Science (1977) 1.41
Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci (1998) 1.41
Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res (1993) 1.41
Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem (1992) 1.40
Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol (1996) 1.40
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation (1998) 1.40
Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res (1995) 1.40
The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis. Connect Tissue Res (1976) 1.39
Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem (2000) 1.39
Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol (1991) 1.39
Modes of intermolecular cross-linking in mature insoluble collagen. J Biol Chem (1965) 1.38
Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol (1996) 1.38
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J Biol Chem (1996) 1.36
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J (1995) 1.34
The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol (1974) 1.32
Collagen self-assembly in vitro. Differentiating specific telopeptide-dependent interactions using selective enzyme modification and the addition of free amino telopeptide. J Biol Chem (1981) 1.27
Solvent-dependent changes in proteoglycan subunit conformation in aqueous guanidine hydrochloride solutions. J Biol Chem (1974) 1.27
The mechanism of nucleation for in vitro collagen fibril formation. Biopolymers (1977) 1.27
92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol (1995) 1.26
Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem (1997) 1.26
Dentin phosphoprotein: an extracellular calcium-binding protein. Biochemistry (1977) 1.24
X-ray absorption microtomography (microCT) and small beam diffraction mapping of sea urchin teeth. J Struct Biol (2002) 1.22
Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis (1998) 1.22
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res (1992) 1.21
Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem (1994) 1.19
MMP-2: expression, activation and inhibition. Enzyme Protein (1996) 1.19
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol (1994) 1.19
Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J Natl Cancer Inst (2001) 1.18
Mapping of magnesium and of different protein fragments in sea urchin teeth via secondary ion mass spectroscopy. J Struct Biol (2006) 1.18
Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res (1992) 1.18
Matrix proteins of the teeth of the sea urchin Lytechinus variegatus. J Exp Zool (1986) 1.17
Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation (1997) 1.17
A transmission electron microscope study using vitrified ice sections of predentin: structural changes in the dentin collagenous matrix prior to mineralization. J Struct Biol (2000) 1.17
Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature (1975) 1.16
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res (1993) 1.16
Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem (1995) 1.16
Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer (1994) 1.14
Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol (2001) 1.14
Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging (1997) 1.13
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood (1997) 1.12
Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res (1992) 1.11
Type I collagen-phosphophoryn interactions: specificity of the monomer-monomer binding. J Struct Biol (1998) 1.11
Transmission electron microscopy characterization of macromolecular domain cavities and microstructure of single-crystal calcite tooth plates of the sea urchin Lytechinus variegatus. J Struct Biol (2005) 1.11
Degradation of basement-membrane collagen by neutral proteases from human leukocytes. Eur J Biochem (1980) 1.10
Characterization of heparan sulfate-proteoglycan of glomerular basement membranes. Proc Natl Acad Sci U S A (1984) 1.09
Characterization of nuclei in in vitro collagen fibril formation. Biopolymers (1977) 1.09
Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol (1991) 1.09
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis (1996) 1.09
Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis (1996) 1.08
The solubilization of mature, polymeric collagen fibrils by lyotropic relaxation. Biochim Biophys Acta (1970) 1.07
Type I collagen shows a specific binding affinity for bovine dentin phosphophoryn. Calcif Tissue Int (1986) 1.06
The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res (1993) 1.06
Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest (1991) 1.06
Bovine dentin phosphophoryn: calcium ion binding properties of a high molecular weight preparation. Calcif Tissue Int (1987) 1.06
Phosphophoryns-major noncollagenous proteins of rat incisor dentin. Calcif Tissue Res (1978) 1.05
Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis (1995) 1.05